Join Pharma Partnering Webinars with MSD and Viatris Ahead of BIO 2024
14 March 2024
In the lead up to BIO 2024 in San Diego, Austrade is offering two interactive pharma partnering webinars with MSD and Viatris, in April.
This is an opportunity to hear directly from MSD and Viatris’ US Business Development & Licensing teams, ask them questions, and apply to meet either virtually or in-person during BIO San Diego.
Each session will be 1 hour in duration, starting with an introduction to both of the companies priority areas and partnering approaches, followed by Q&A.
Following these events, all participants will be invited to submit Expression of Interest (EOI) forms to request private meetings with MSD and Viatris either virtually or in-person during BIO San Diego.
EOI responses will be evaluated by MSD and Viatris and introductions facilitated by Austrade after the evaluation process.
Session 1 - MSD: Wednesday 10 April, 9 – 10 am AEST
*Suited to researchers and companies across any stage of therapeutic or platform development.
Speakers from MSD include:
- Nikhil Mutyal Ph.D., Oncology & neuroscience
- Michelle Booden, Immunology, infectious diseases & vaccines
- Russell DeKelver, Cardiometabolic diseases, renal, respiratory & ophthalmology
Session 2 - Viatris: Tuesday 23 April, 10 – 11 am AEST
*Suited therapies such as cell and gene therapy are not in scope for Viatris.
Speaker:
- Brett Roberts, Head of Viatris Business Development ANZ, Global Business Development
These events are open to all Australian researchers and companies, regardless of attendance at BIO San Diego.